19/06/2024 - Projects, Research

Decoding depression amidst COVID-19: a comprehensive analysis of genetic and environmental stressors by GCAT

As a strategic initiative under IGTP, GCAT (Genomes for Life) continues to make substantial contributions to public health knowledge. The latest GCAT study, conducted through the COVICAT initiative, signed by Ximena Goldberg and Rafael de Cid, sheds light on the complex interplay between genetic predispositions and environmental stressors in determining depression risk, especially during the COVID-19 lockdown. Published in Scientific Reports.

11/06/2024 - Research

Scientists show the key role of spleen and extracellular vesicles in cryptic malaria infections

Recent research led by Carmen Fernández-Becerra and Hernando A del Portillo from ISGlobal and IGTP has provided new insights into the role of the spleen in malaria, specifically in infections caused by Plasmodium vivax.

29/05/2024 - Outreach, Projects, Research

The project "Workshop #20 - Neural Networks", a space for collaboration, experimentation, and research between science, art, technology, and society

The activity of Èpica Foundation La Fura dels Baus, co-financed by the Spanish Foundation for Science and Technology (FECYT), in collaboration with Germans Trias i Pujol Research Institute (IGTP), Institute of Biomedical Research of Barcelona (IIBB-CSIC), Polytechnic University of Catalonia, and Computer Vision Center (CVC-UAB), took place from 14 to 26 May at Casa de l'Aigua (Trinitat Nova) in Barcelona. The results were presented last weekend before more than 200 people.

21/05/2024 - Projects, Research

Researcher Sofía España receives a €140,000 grant from the Spanish Association Against Cancer

Dr Sofía España, a researcher from the Cancer Mechanisms and Pathways Group at IGTP and the Badalona Applied Research Group in Oncology (B·ARGO) IGTP-Institut Català d'Oncologia (ICO), has been awarded one of the prestigious Clínico Junior Grants by the Spanish Association Against Cancer. This grant will enable her to balance her clinical duties with research, focusing on the development of a minimally invasive diagnostic tool to classify different types of colorectal cancer, advancing towards precision medicine.

14/05/2024 - Research

A new drug shows potential benefits in the recovery of patients after a heart attack

Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial effects of the novel drug Sacubitril/Valsartan in the management of myocardial infarction (MI).

09/05/2024 - Research

A study reveals the need to review temperature control measures in hospitals to manage legionella

A work of the Clinical and Environmental Infectious Diseases Study Group (CEID) at IGTP, led by Dr Laura Gavaldà from the Bellvitge University Hospital, in collaboration with the ICO and the Barcelona Public Health Agency, has disclosed significant findings on the survival of the Legionella pneumophila bacterium in hospital water systems.

06/05/2024 - Projects, Research

DATOS-CAT Project: Integration and Analysis of Biomedical Databases

The collaborative action DATOS-CAT aims to enhance the visibility and scientific impact of population-based cohorts created in Catalonia. Additionally, it seeks to enrich the procedures used in these cohorts, promoting their applicability in other similar contexts. To achieve this, it focuses on improving data interoperability, thereby facilitating their exploitation and use in scientific research.

25/04/2024 - Research

Plasmodium vivax, a Human Malaria Parasite Resilient to Elimination

Why is it so difficult to eliminate the "forgotten" malaria parasite Plasmodium vivax? The PvREX research group at ISGlobal and IGTP presents recent scientific data.

19/04/2024 - Research

COVID-19 increases the risk of severe cardiovascular problems in people with HIV

According to a study led by CEEISCAT-IGTP and conducted with the PISCIS cohort, individuals with HIV who have had COVID-19 face a 30% higher risk of developing cardiovascular diseases.

03/04/2024 - Campus Can Ruti, Research

First cardiac bioimplants for the treatment of patients with myocardial infarction using umbilical cord stem cells

The results of a pioneering study by IGTP and BST support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularisation of the affected area.